The present invention relates to a kit and an in vitro method for detecting and characterizing the degradation of a particular organ or tissue, on the basis of the analysis of the presence of at least one specific methylated cell-free DNA in a biological sample.
CGenetix develops the new generation of liquid biopsy biomarkers to evaluate organs damages during a pathological process.